• Home
  • North West Genomic Laboratory Hub
Important notice for haemato-oncology service users (Mat 2023): We have transitioned to a new BCR-ABL1 quantitative assay and have introduced qualitative BCR-ABL1 fusion detection for patients at diagnosis. Full details can be found here.
Important Notice (December 2022):
Dear service users, Due to Royal Mail postal strikes, samples sent to the NWGLH may be delayed reaching both the Manchester and Liverpool sites. If the referral is urgent it is strongly recommended that samples are either sent by courier or taxi to the appropriate site.

Important Notice on referring pregnancy loss samples for testing (October 2022):

To improve and streamline our pregnancy loss genomic testing pathway we have developed a Discussion and Consent Form which will come into effect from 1st November. The form should be completed by the referrer with the patient and will inform patient wishes (and our pathway) in the event that a very small tissue sample remains at the laboratory following testing requiring return or sensitive disposal. Please go to our new Pregnancy Loss Referral Guidance page to access the form as well as a Discussion and Consent Letter to Referrers for information and guidance. Alternatively, to navigate manually to our Pregnancy Loss Referral Guidance page, click on ‘Test Information’ on the NWGLH homepage and then go to ‘General Requirements’.

Important Notice (June 2022):
Due to the impact of large-scale transformation, increases in sample numbers and the long-standing impact of COVID-19 there may be delays in the reporting of laboratory results from the North West GLH at Manchester and Liverpool. Urgent test services continue to be prioritised. Please bear with us at this time and avoid contacting the laboratory for the results of routine genomic tests. We thank you for your patience and understanding.
Important Notice For Pathology Labs (June 2022):
Please note we do not accept pathology blocks for testing; these will be returned without processing. Please visit here for detailed information on sample requirements.
Important Notice, ROS1 FISH testing (02/02/2022):
Due to a technical issue with the ROS1 FISH test, all ROS1 testing at the North West GLH Manchester is now being carried out using our next generation sequencing fusion panel. Please accept our apologies for the short notice. Thank you for your understanding.
Please note that as of April 2021, the National Genomic Test Directories have gone live. For further information, please see the attached letters below for Rare Disease, Solid Tumour and Haematology Oncology.

The North West Genomic Laboratory Hub (GLH) is one of a network of seven GLHs across the country, which together forms the new national Genomic Medicine Service. Each GLH is responsible for coordinating services for a particular part of the country.

The NW GLH has been implementing several quality improvements to align systems across the Liverpool and Manchester laboratory sites. Currently, we are rolling out a new standardised report style for services delivered by the NW GLH to improve consistency and uniformity of the information provided on our reports. Please note that the UKAS accreditation symbol does not feature on the report; it is displayed on our website (under ‘Accreditation’) along with relevant links to our schedule of accreditation. If you have any comments or queries regarding the new style of reports, please contact us.